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Abstract
Background: EB1 is a microtubule tip-associated protein that interacts with the APC tumour
suppressor protein and the p150glued subunit of dynactin. We previously reported that an EB1
deletion mutant that retains both of these interactions but does not directly associate with
microtubules (EB1-∆N2-GFP) spontaneously formed perinuclear aggregates when expressed in
COS-7 cells.
Results: In the present study live imaging indicated that EB1-∆N2-GFP aggregates underwent
dynamic microtubule-dependent changes in morphology and appeared to be internally cohesive.
EB1-∆N2-GFP aggregates were phase-dense structures that displayed microtubule-dependent
accumulation around the centrosome, were immunoreactive for both the 20s subunit of the
proteasome and ubiquitin, and induced the collapse of the vimentin cytoskeleton. Fractionation
studies revealed that a proportion of EB1-∆N2-GFP was detergent-insoluble and ubiquitylated,
indicating that EB1-∆N2-GFP aggregates are aggresomes. Immunostaining also revealed that APC
and p150glued were present in EB1-∆N2-GFP aggregates, whereas EB3 was not. Furthermore,
evidence for p150glued degradation was found in the insoluble fraction of EB1-∆N2-GFP
transfected cultures.
Conclusion: Our data indicate that aggresomes can be internally cohesive and may not represent
a simple "aggregate of aggregates" assembled around the centrosome. Our observations also
indicate that a partially misfolded protein may retain the ability to interact with its normal
physiological ligands, leading to their co-assembly into aggresomes. This supports the idea that the
trapping and degradation of co-aggregated proteins might contribute to human pathologies
characterised by aggresome formation.
Background
EB1 is the prototypical member of a highly conserved
family of proteins that localise to centrosomes and grow-
ing microtubule tips [1-3]. EB1 has been shown to directly
interact with microtubules, the adenomatous polyposis
coli (APC) tumour suppressor protein and the p150glued
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subunit of the dynein/dynactin microtubule motor com-
plex [3-9]. In a previous study of a series of EB1 deletion
mutants we noted that an EB1 protein lacking its N-termi-
nal 100aa and fused at its C-terminus to GFP (EB1-∆N2-
GFP) spontaneously formed perinuclear aggregates in
transfected COS-7 cells fixed and examined by immunos-
taining [3]. The present study represents a further charac-
terisation of these aggregates.
This phenomenon was considered worthy of investigation
for a number of reasons. Removal of the N-terminal
100aa of EB1 to generate EB1-∆N2-GFP neatly removes
one of the major structural features of the protein, a cal-
ponin homology (CH) domain implicated in the micro-
tubule-binding ability of EB1 [3,9-11], while leaving the
region that mediates the interactions with APC and
p150glued intact. Consistent with this, EB1-∆N2-GFP
does not localise to microtubules in transfected cells
whereas a GST-EB1-∆N2 recombinant fusion protein
binds to both APC and p150glued in vitro [3]. The behav-
iour of EB1-∆N2-GFP in transfected cells might therefore
reveal new information about EB1 folding and function.
In addition, EB1-∆N2-GFP aggregation resembled a cellu-
lar response to the presence of misfolded, proteolytically
resistant proteins termed aggresome formation [see ref
[12] for a recent review]. Aggresomes assemble around
centrosomes in a process that requires microtubules and
dynein/dynactin-mediated transport [13-15]. As EB1-
∆N2-GFP retains the ability to directly interact with
p150glued, an examination of the aggregation of this pro-
tein in transfected cells might yield further insight into the
process of aggresome formation. Furthermore, it seemed
possible that the perinuclear EB1-∆N2-GFP aggregates
might represent a structure unrelated to aggresomes and
instead arise from dominant-negative effects on the nor-
mal EB1/p150glued interaction. We therefore reasoned
that detailed examination of EB1-∆N2-GFP aggregation
might shed further light on the normal function of this
interaction within cells.
Results
EB1-∆N2-GFP aggregate dynamics in living cells
We first examined the behaviour of EB1-∆N2-GFP using
time-lapse fluorescence microscopy in living COS-7 cells.
In a minority of cells EB1-∆N2-GFP displayed a diffuse
cytoplasmic distribution with specific labelling of the cen-
trosome (not shown), as described previously in fixed
cells [3]. The remaining cells contained single large peri-
nuclear aggregates of the fusion protein against a back-
ground of diffuse cytoplasmic fluorescence, with smaller,
motile, non-perinuclear structures sometimes apparent
(ie see additional file 2). Perinuclear aggregates at this
time (14–18 h post-transfection) typically had a compact
morphology and were less than half the size of the
nucleus in the transfected cell (Fig. 1; additional files 1
and 2).
Time-lapse imaging of transfected cells revealed that the
EB1-∆N2-GFP aggregates consisted of variably sized,
brightly fluorescent foci closely associated with structures
of lower fluorescence intensity (Fig. 1A; additional file 1;
additional file 2, sequence 1), with a dense appearance in
phase contrast images (Fig. 1B and 1C, arrows; additional
file 2, sequence 2). Aside from this, phase contrast imag-
ing did not reveal any obvious differences in cellular mor-
phology when transfected cells were compared with
adjacent, untransfected cells (Fig. 1C, additional file 2,
sequence 2). EB1-∆N2-GFP aggregates exhibited constant
minor changes in shape while maintaining a relatively
cohesive overall structure. However, occasional larger
changes in morphology were also observed, typically a
rapid extrusion of ribbon-like structures away from the
main body of the aggregate (Fig 1. panels D-I, arrows;
additional file 3, sequence 1; see also additional file 1).
This behaviour suggested that the aggregates consisted of
brighter particles linked by a less fluorescently intense
matrix. These extrusions appeared relatively stable, but re-
incorporation into the main body of the aggregate was
also seen (Fig. 1 panels G-I; additional file 3, sequence 2).
The speeds of extrusion and retraction were consistent
with previous observations of microtubule motor-medi-
ated transport in living cells. For example, in the
sequences shown in additional file 3 particle tracking
analysis indicated that extrusion occurred at an average
speed of 0.14 µm/s whereas retraction occurred at a speed
of around 0.1 µm/s, although peak speeds of movement
in other time lapse sequences sometimes approached 2.5
µm/s. Addition of the microtubule depolymerising drug
nocodazole to the cell culture medium at concentrations
known to induce microtubule disassembly in COS-7 cells
followed by imaging every 30 min over a time course of
90 min after drug addition revealed the appearance of
small spots of fusion protein scattered throughout the
cytoplasm and an increase in diffuse cytoplasmic fluores-
cence. No evidence of shrinkage or dispersal of the perinu-
clear aggregates was seen over this timescale (Fig. 2 panels
A and B, arrows). However, both perinuclear and dis-
persed aggregates were completely immobile in the pres-
ence of nocodazole (Fig. 3, panels A and B; additional file
4). When nocodazole was removed and fresh medium
added these aggregates gained motility (Fig. 3, additional
file 5) and perinuclear accumulations rapidly assembled,
progressively increasing in size and intensity (Fig. 2, pan-
els C-F). Time-lapse imaging revealed smaller structures
moving rapidly towards and incorporating into the peri-
nuclear aggregates (Fig. 3; additional file 5). Coalescence
of cytoplasmic aggregates before their transport to the
perinuclear accumulations was also evident (additional
file 5). Particle movement after nocodazole wash out was
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Page 3 of 14
(page number not for citation purposes)
Live imaging of EB1-∆N2-GFP aggregates in transfected COS-7 cellsFigure 1
Live imaging of EB1-∆N2-GFP aggregates in transfected COS-7 cells. Panel A. Single frame from additional file 1 showing the 
structure of EB1-∆N2-GFP aggregates. Bar = 5 µm. Panel B. Single frame from additional file 2, sequence 1 showing aggresome 
(arrows) behaviour in two transfected cells. Panel C. Single frame from additional file 2, sequence 2 that shows the cells from 
sequence 1 imaged using phase-contrast microscopy to reveal adjacent untransfected cells. This sequence was begun 30s after 
the completion of sequence 1. Arrows indicate aggresome location in the transfected cells. Bar = 10 µm. Panels D-F. Three 
frames from additional file 3, sequence 1 showing the extension of a linear structure from an EB1-∆N2-GFP aggregate. Panels 
G-I. Three frames from additional file 3, sequence 2 showing the retraction of this structure. Bar for D-I = 5 µm. Times shown 
are relative to the first frame in each sequence. Panels A and D-I were obtained using a 63X oil immersion lens. Panels B and C 
were obtained using a 40X dry lens.
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discontinuous and occasionally bidirectional, but with an
obvious bias towards retrograde movement (in both fre-
quency and persistence) as would be expected for the
assembly of a perinuclear aggregate. Again, average speeds
of particle movement were consistent with microtubule
motor-mediated translocation at around 0.1 µm/s. In
sum, this data indicated that that the formation and
dynamic behaviour of the perinuclear EB1-∆N2-GFP
aggregates was critically dependent upon the presence of
an intact microtubule cytoskeleton.
EB1-∆N2-GFP aggregates are aggresomes
The behaviour and morphology of the EB1-∆N2-GFP
structures in living cells was reminiscent of the previously
reported characteristics of aggresomes [12-14]. Aggre-
somes form around the centrosome when the accumula-
tion of an aberrantly folded protein exceeds the ability of
the cells protein degradation apparatus to dispose of it
[18], and they typically share certain common features.
Perinuclear EB1-∆N2-GFP aggregate formation is microtubule-dependentFigure 2
Perinuclear EB1-∆N2-GFP aggregate formation is microtu-
bule-dependent. Panel A. Still image from living cells contain-
ing EB1-∆N2-GFP aggregates. Panel B. The cells shown in 
panel A following 90 min incubation with 5 µg/ml nocoda-
zole. Arrows indicate the presence of small peripheral aggre-
gates. Panel C. Still image from a living cell expressing EB1-
∆N2-GFP following 4 h incubation in 5 µg/ml nocodazole. 
Panels D-F. Images of the cell shown in panel C at 30 min 
intervals following nocodazole wash out. The formation of a 
single perinuclear aggregate is seen. Bar = 10 µm.
Microtubule-dependent movement of peripheral EB1-∆N2-GFP aggregatesFigure 3
Microtubule-dependent movement of peripheral EB1-∆N2-
GFP aggregates. Panels A and B. Single frames from additional 
file 4 showing a living cell expressing EB1-∆N2-GFP after 2 h 
incubation in nocodazole. All EB1-∆N2-GFP aggregates are 
immobile. Bar = 10 µm. Panels C-F. Single frames from addi-
tional file 5 showing a living cell expressing EB1-∆N2-GFP 
during the recovery phase following nocodazole wash out. 
The retrograde transport of a peripheral aggregate and its 
incorporation into a large perinuclear aggregate is arrowed. 
Times shown are relative to the first frame in the sequence. 
Bar = 10 µm.
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For example, like the EB1-∆N2-GFP aggregates examined
here, aggresome formation but not maintenance is micro-
tubule dependent and in the presence of microtubule
poisons newly synthesised protein is found in aggregates
dispersed throughout the cytoplasm [12]. We therefore
fixed and immunostained EB1-∆N2-GFP transfected
COS-7 cells for other aggresomal markers.
Co-immunostaining for GFP and either α-tubulin (Fig. 4
panels A-C) or γ-tubulin (not shown) confirmed that EB1-
∆N2-GFP aggregates formed around the centrosome in
transfected cells. No γ-tubulin immunoreactivity was seen
in the aggregates themselves, unlike some aggresomes
observed in different systems [19,20]. Co-staining for α-
tubulin also indicated that in cells with small aggregates
the radial microtubule cytoskeleton was either slightly
deformed in the region of the aggregation or unaffected by
the presence of the aggregates (Fig. 4 panels A-C). In some
cells, particularly those harbouring large aggregates, evi-
dence of extensive microtubule disorganisation was seen
(not shown). This is not a widely reported consequence of
aggresome formation and in this case may reflect a domi-
nant-negative inhibition of endogenous EB1 function,
since we have previously noted the same effect in COS-7
cells expressing different EB1 N-terminal deletion
mutants [3]. Further co-staining experiments demon-
strated that the aggregates were immunopositive for both
the 20s subunit of the 26S proteasome (Fig. 5 panels A-C)
and ubiquitin (Fig. 5 panels D-F; refs [18,21]), and indi-
cated that they induced the collapse of the vimentin
cytoskeleton (Fig. 5 panels G-I; ref [13]). However, the ER
resident chaperone BiP/GRP78 was not detected in EB1-
∆N2-GFP aggregates (not shown; ref [18]). These data
indicate that the EB1-∆N2-GFP aggregates bear many of
the characteristic hallmarks of an aggresome formed by a
misfolded cytosolic protein.
EB1-∆N2-GFP aggregates contain APC
EB1-∆N2-GFP retains the ability to interact with APC [3].
To examine whether this interaction might target APC to
EB1-∆N2-GFP aggresomes we co-immunostained trans-
fected cells with antibodies to APC and GFP and exam-
ined them using confocal microscopy. Robust APC
immunostaining was detected in the EB1-∆N2-GFP aggre-
gates (Fig. 6 panels A-F). Closer examination of single
confocal sections indicated that APC immunostaining in
the aggresomes was more heterogeneous that that
obtained for GFP, but where present completely over-
lapped with GFP-positive structures (Fig. 6 panels D-F).
This heterogeneity may reflect APC antibody accessibility
problems in the centre of the dense aggresomal matrix.
We were unable to investigate whether endogenous EB1
was present in the aggresomes as EB1-∆N2-GFP contains
the epitope recognised by the EB1 antibody used here [3].
However, another member of the conserved EB1 protein
family, EB3, is also known to interact with APC and
p150glued [9] and to localise to growing microtubule tips
[22]. COS-7 cells co-express EB1 and EB3 (JMA, unpub-
lished observations). We therefore examined EB3 distri-
bution in transfected cells and found no evidence for EB3
in the EB1-∆N2-GFP aggregates (Fig. 6 panels G-I). This
indicates that EB3 does not associate with EB1-∆N2-GFP
and suggests that it cannot interact with APC or
EB1-∆N2-GFP aggregates are associated with the centrosomeFigure 4
EB1-∆N2-GFP aggregates are associated with the centrosome. Panels A-C. Cells expressing EB1-∆N2-GFP were fixed and co-
immunostained for GFP (green, panel A) and α-tubulin (red, panel B). A merged image is shown in panel C. EB1-∆N2-GFP 
aggregates are clustered around the centrosome. Bar = 10 µm.
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EB1-∆N2-GFP aggregates are aggresomesFigure 5
EB1-∆N2-GFP aggregates are aggresomes. Cells expressing EB1-∆N2-GFP were fixed and co-immunostained for GFP (green, 
panels A, D and G) and either the 20s proteosomal subunit (red, panel B), ubiquitin (red, panel E) or vimentin (red, panel H). 
Merged images are shown in panels C, F and I. All three aggresome markers were present in EB1-∆N2-GFP aggregates. Bar = 
10 µm.
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APC is present in EB1-∆N2-GFP aggresomesFigure 6
APC is present in EB1-∆N2-GFP aggresomes. Panels A-C. Cells expressing EB1-∆N2-GFP were fixed and co-immunostained 
for GFP (green, panel A) and APC (red, panel B). A merged image is shown in panel C. APC is seen in aggresomes in trans-
fected cells and at peripheral sites in adjacent untransfected cells. Bar = 10 µm. Panels D-F. A single 0.365 µm confocal section 
through a cell expressing EB1-∆N2-GFP. APC immunoreactivity (panel E) in aggresomes is heterogeneous but only seen in 
association with GFP immunoreactivity (panels D and F). Bar = 5 µm. Panels G-I. Cells expressing EB1-∆N2-GFP were fixed 
and co-immunostained for GFP (green, panel G) and EB3 (red, panel H). EB3 is seen at microtubule tips but is not present in 
EB1-∆N2-GFP aggresomes. Bar = 20 µm. Images in panels A-C and G-I are projections of confocal image stacks.
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p150glued in the aggresomes, possibly because the EB1/
EB3 binding sites in these proteins are already filled by
EB1-∆N2-GFP.
Dynein/dynactin components are present in EB1-∆N2-GFP 
aggresomes
EB1-∆N2-GFP can also directly interact with the
p150glued subunit of dynactin [3]. Co-immunostaining
consistently revealed strong p150glued immunostaining
in EB1-∆N2-GFP aggregates (Fig. 7 panels A-F). As with
APC, close examination of single confocal sections indi-
cated that p150glued immunoreactivity overlapped with
but was more heterogeneous than that seen for GFP in
these structures (Fig. 7 panels D-F). Immunostaining for
p150glued was also prominent at centrosomes (a normal
intracellular localisation for this protein) surrounded by
EB1-∆N2-GFP aggregates (Fig. 7 panels D-F, arrows). Co-
immunostaining also revealed the presence of both the
CDIC and p50dynamitin subunits of dynein/dynactin in
EB1-∆N2-GFP aggresomes (Fig. 7 panels G-L). As with
p150glued both of these proteins displayed a heterogene-
ous distribution in the aggresome and were also present at
the centrosome. In general, and bearing in mind the prob-
lems involved in trying to compare staining intensities for
different proteins, aggresomal immunostaining for these
proteins appeared to be weaker and more variable than
that obtained for p150glued. For example, strong immu-
nostaining for both CDIC and p50dynamitin was
observed most consistently in larger aggregates but was
less apparent in smaller aggregates.
Fractionation and Western blotting analysis of EB1-∆N2-
GFP expressing cells
A characteristic of aggresomes is their insolubility in non-
ionic detergent solutions [13,14]. We therefore performed
a simple fractionation by extracting cells in 0.1% Triton X-
100 in PBS and separating soluble and insoluble fractions
by centrifugation. The resulting fractions were examined
using SDS-PAGE and Western blotting. As shown in Fig.
8A, immunoblotting with a GFP-specific antibody
revealed the presence of single bands representing GFP,
EB1-GFP or EB1-∆N2-GFP in the soluble fraction of the
relevant transfected cell extract (arrowed). Immunoblot-
ting with an EB1-specific antibody gave a similar result for
EB1-GFP and EB1-∆N2-GFP and also revealed that the lev-
els of endogenous soluble EB1 were unchanged by trans-
fection. Immunoblotting with an EB3-specific antibody
detected a single immunoreactive band. We also probed
soluble cell fractions with antibodies specific for the
p150glued, p50dynamitin and CDIC subunits of the
dynein/dynactin complex. This indicated that the levels of
these proteins in the soluble fraction were unaffected by
the expression of GFP or either of the EB1-derived fusion
proteins (Fig. 8B).
These analyses were then repeated on the detergent-insol-
uble fraction from transfected cells. GFP immunoblotting
revealed two immunoreactive bands in the insoluble frac-
tion of cells expressing GFP (Fig. 8C). The smaller of these
(arrowed) corresponded to the expected molecular weight
of GFP whereas the larger (arrowhead) is consistent with
the size of a monoubiquitylated GFP molecule, suggesting
that a proportion of overexpressed GFP in COS-7 cells
might be turned over by normal cellular mechanisms of
protein degradation. Only weak immunolabelling was
detected for EB1-GFP in overexposed blots (Fig. 8C,
arrowed), consistent with previous observations showing
endogenous EB1 to be highly soluble (1). In contrast,
EB1-∆N2-GFP was highly insoluble in transfected cell
extracts (Fig. 8C). Furthermore, in addition to a major
band corresponding to the expected size of EB1-∆N2-GFP
(arrowed), at least two higher molecular weight bands
were also detected (arrowheads). The equal spacing
between these bands suggests that these represent ubiquit-
ylated forms of the insoluble protein, consistent with the
positive ubiquitin immunoreactivity observed in EB1-
∆N2-GFP aggregates by immunostaining of transfected
cells (Fig. 5 panels D-F). The presence of at least one
higher molecular weight species of EB1-∆N2-GFP was
confirmed when blots were probed with the EB1 antibody
and examined after overexposure (Fig. 8D, arrowhead).
EB3 and the dynein/dynactin components p50dynamitin
and CDIC were essentially undetectable in the insoluble
fraction of any of the transfected cell extracts (not shown).
p150glued was detected in the insoluble fraction of all
extracts (Fig. 8C, arrowed) but no evidence for an enrich-
ment of insoluble p150glued in cells expressing EB1-∆N2-
GFP was found. However, two lower molecular weight
species of approximately 45 and 15 kDa were specifically
detected by the p150glued monoclonal antibody in the
insoluble fraction of cells expressing EB1-∆N2-GFP (Fig.
8C, arrowheads).
Discussion
The data presented in this study indicate that the perinu-
clear aggregates formed in cells expressing EB1-∆N2-GFP
are aggresomes, although the underlying reason for their
formation by this fusion protein remains unclear. Two
mechanisms seem possible. First, the initial aggregation
occurs as a direct consequence of the interaction between
EB1-∆N2-GFP and p150glued, perhaps coupled to aber-
rant retrograde transport of this complex, and aggresome
formation occurs subsequent to this. A second possibility
is that EB1-∆N2-GFP misfolds, becomes refractive to pro-
teolytic degradation and thereby triggers the formation of
an aggresome. Neither EB1-GFP nor any of the other GFP-
tagged EB1 deletion mutants generated in our laboratory,
including those that do not interact with microtubules but
retain an ability to bind APC and p150glued, form aggre-
BMC Cell Biology 2005, 6:17 http://www.biomedcentral.com/1471-2121/6/17
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Dynein/dynactin subunits are present in EB1-∆N2-GFP aggresomesFigure 7
Dynein/dynactin subunits are present in EB1-∆N2-GFP aggresomes. Panels A-C. Cells expressing EB1-∆N2-GFP were fixed and 
co-immunostained for GFP (green, panel A) and p150glued (red, panel B). A merged image is shown in panel C. p150glued is 
seen in aggresomes. Bar = 10 µm. Panels D-F. A single 0.365 µm confocal section through a cell expressing EB1-∆N2-GFP. 
p150glued immunoreactivity in aggresomes (panel E) is heterogeneous but only seen in association with GFP immunoreactivity 
(panels D and F). Centrosomal immunostaining is also observed (arrow). Bar = 5 µm. Panels G-L. Cells expressing EB1-∆N2-
GFP were fixed and co-immunostained for GFP (green, panel G) and either CDIC (red, panel H) or p50dynamitin (red, panel 
K). Merged images are shown in panels I and K. Heterogeneous CDIC and p50dynamitin immunostaining is seen in aggresomes 
and at centrosomes. Bars = 10 µm. Images in panels A-C and G-L are projections of confocal image stacks.
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Fractionation and Western blotting analysis of EB1-∆N2-GFP aggregatesigure 8
Fractionation and Western blotting analysis of EB1-∆N2-GFP aggregates. COS-7 cells were transfected with GFP, EB1-GFP or 
EB1-∆N2-GFP for 24 h before extraction in detergent-containing buffer and separation into soluble (panels A and B) and insol-
uble (panels C and D) fractions and analysis by SDS-PAGE and Western blotting. Panel A. GFP immunoblotting of soluble 
fractions revealed the presence of single immunoreactive bands for GFP, EB1-GFP and EB1-∆N2-GFP (arrows). Non-specific 
cross-reacting bands are evident using this polyclonal antibody. EB1 immunoblotting revealed single bands for EB1-GFP, EB1-
∆N2-GFP and endogenous EB1 (arrows). EB3 immunoblotting revealed a single immunoreactive band in all soluble fractions. 
Panel B. Immunoblotting for p150glued, p50dynamitin and CDIC indicated that the level of these proteins in soluble fractions 
were similar in all transfections. Panel C. GFP immunoblotting revealed the presence of two immunoreactive bands in the 
insoluble fraction of GFP transfected cells (arrow and arrowhead), at least three bands in EB1-∆N2-GFP transfected cells 
(arrow and arrowheads) and a single weak band for EB1-GFP (arrow). An overexposed image is shown to highlight the acces-
sory bands. EB1 immunoblotting revealed the presence of two immunoreactive bands in EB1-∆N2-GFP insoluble fractions 
(arrow and arrowhead). This blot is also shown overexposed. Panel D. Immunoblotting detected p150glued in the insoluble 
fraction of all extracts (arrow). Two lower molecular weight bands were specifically detected in the insoluble fraction of EB1-
∆N2-GFP transfected cells (arrowheads). The 43 kDa non-specific band present in the GFP and p150glued panels was present 
in immunoblots performed on insoluble cellular fractions regardless of the primary antibody used.
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somes in transfected cells [3]. This suggests that the first
possibility is less likely. Furthermore, our Western blot-
ting analyses indicated that cell extracts from cultures
transfected with the EB1-∆N2-GFP construct contained
significantly more fusion protein than those from cultures
transfected with the EB1-GFP construct (Fig. 8). Since the
transfection efficiency for the EB1-GFP and EB1-∆N2-GFP
constructs was similar, equal amounts of transfected cell
extracts were analysed and the base expression vector used
for both constructs was identical, the best explanation for
the higher levels of EB1-∆N2-GFP relative to EB1-GFP in
our experiments is that EB1-GFP was turned over
normally within the cell whereas EB1-∆N2-GFP was not.
This data therefore supports the second mechanism sug-
gested above. However, if aggregation is a response to
EB1-∆N2-GFP misfolding, then the presence of both
p150glued and APC in the aggregates suggests that this
misfolding is partial since the binding sites for both of
these proteins appears to be functional (Figs. 6 and 7; ref
[3]). We therefore propose that EB1-∆N2-GFP in COS-7
cells adopts a conformation where APC and p150glued
binding are maintained but the fusion protein is recog-
nised by the cellular stress response pathway for mis-
folded proteins, perhaps as a result of a disordered N-
terminal region arising from the loss of the CH domain
from the EB1 N-terminus. As this partially misfolded pro-
tein is resistant to degradation it accumulates within the
cytoplasm and an aggresome is formed.
Other investigators have previously described the forma-
tion of aggresomes by a cytosolic GFP fusion protein
(GFP-250) in living cells [14]. EB1-∆N2-GFP aggresome
formation appeared to correlate well with that observed
for GFP-250, particularly during aggresome assembly fol-
lowing nocodazole treatment and wash out. However,
previous ultrastructural studies have suggested that aggre-
somes represent an "aggregate of aggregates" formed by
an accumulation of individual particles without further
coalescence into a cohesive structure [12-14]. Our time-
lapse studies suggest that this is not the case with EB1-
∆N2-GFP. In our system aggresomes exhibited dynamic
microtubule-dependent linear extensions. These typically
resembled beads on a string with one end remaining
attached to the main structure of the aggresome. Detach-
ment and anterograde movement of individual particles
from aggresomes was never seen. These observations indi-
cate that the brighter structures in EB1-∆N2-GFP aggre-
somes must be linked in some way and, since extensions
were never seen to fully detach from aggresomes, this link-
age is strong enough to resist the forces generated by
microtubule motors. Together with our data showing that
microtubules are not necessary to maintain the pericen-
trosomal location of pre-existing EB1-∆N2-GFP aggre-
somes, this suggests that these structures possess an
inherent cohesiveness and are not simply a collection of
individual elements maintained in close proximity to the
centrosome by dynein motor activity. At present it
remains unclear whether this dynamic behaviour is a uni-
versal feature of aggresomes or is restricted to those
formed by EB1-∆N2-GFP. However, we note that associa-
tions with kinesin II have recently been described for both
p150glued [23] and APC [24]. Since both proteins are
clearly present in EB1-∆N2-GFP aggregates these interac-
tions could potentially contribute to the dynamic behav-
iour of these structures.
Recent studies of aggresome formation by mutant CFTR
and SOD proteins in cells treated with proteosome inhib-
itors indicated that the dynein/dynactin components
CDIC, p50dynamitin and p150glued were all recruited to
aggresomes [15,25]. This raises the possibility that the
p150glued observed in EB1-∆N2-GFP-induced aggre-
somes was present as a normal cofactor for aggresome for-
mation rather than as a specific EB1-∆N2-GFP ligand.
Furthermore, an increase in the amounts of p150glued
and p50dynamitin in the detergent insoluble fraction of
cells containing mutant SOD-induced aggresomes was
reported [25]. In our experiments no increase in the
amount of insoluble full-length forms of these proteins
was observed. However, in contrast to previous studies we
found lower molecular weight p150glued species in the
detergent-insoluble fraction of cells expressing EB1-∆N2-
GFP. The p150glued antibody used in this study recog-
nises an epitope at the N-terminus of the protein [26], the
same region that mediates the EB1-p150glued interaction
[3] but distinct from the regions responsible for the inter-
actions with other dynein/dynactin subunits [8]. It seems
possible that the bands detected in our immunoblots rep-
resent N-terminal p150glued fragments tightly bound to
insoluble EB1-∆N2-GFP and inaccessible to the proteo-
some. An analogous mechanism has been proposed to
explain the limited proteolytic processing of NF-κB pre-
cursors, where it is suggested that a close association with
a partner molecule inhibits the processive degradation of
the NF-κB p50 domain [27]. To explain the discrepancies
between our data and that presented in the study of
mutant SOD-induced aggresomes we therefore propose
that in the latter case the dynactin complex is recruited to
but not trapped within aggresomes as part of a normal cel-
lular response, whereas in our system the aggresome-asso-
ciated p150glued is tightly bound to EB1-∆N2-GFP.
Subsequent degradation of exposed regions of the mole-
cule destroys the binding sites for p150glued-associated
dynein/dynactin subunits, precluding their stable co-
incorporation into the aggresome. However, binding to
proteolytically-resistant EB1-∆N2-GFP molecules pre-
serves the p150glued fragments detected by the mono-
clonal antibody used in our study.
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Conclusion
In this work we were fortunate in being able to examine
aggresome formation by a defined cytosolic protein that
possesses direct interactions with two other well-charac-
terised proteins, p150glued and APC. This allowed us to
show that these proteins were present in the aggresomes
arising from EB1-∆N2-GFP expression in transfected cells.
Our data therefore suggests that a misfolded protein can
trap its normal endogenous cellular ligands in an aggre-
some, potentially resulting in the degradation of these
partners. This could have implications for our under-
standing of human diseases thought to involve protein
misfolding and the formation of aggresome-like struc-
tures, such as Parkinsons disease and other neurodegener-
ative disorders [12]. Our data provides a proof of principle
that the pathologies characteristic of these diseases could
arise in part from the inappropriate trapping and degrada-
tion of the normal physiological partners of misfolded
proteins in aggresomes and inclusion bodies.
Methods
Cells
COS-7 cells were cultured and drug treatments performed
as described previously [1]. Transfections were performed
using GeneJuice (Novagen) according to the manufactur-
ers instructions. Manual counting of GFP immunostained
transfected cell populations indicated that transfection
efficiencies at 18 h post-transfection were consistently in
the region of 60% for the GFP expression plasmid and
somewhat lower at around 25% for the EB1-GFP and EB1-
∆N2-GFP expression plasmids.
Antibodies and reagents
Monoclonal antibodies specific for EB1, EB3, p150glued
and p50dynamitin were obtained from Transduction Lab-
oratories. Monoclonal antibodies specific for γ-tubulin
and cytoplasmic dynein intermediate chain (CDIC) were
obtained from Sigma. A mouse monoclonal antibody spe-
cific for BiP was obtained from BD Biosciences. A rat anti
α-tubulin antibody was obtained from Serotec. Rabbit
polyclonal antibodies against ubiquitin and the 20S pro-
teosomal subunit were obtained from DAKO and Affiniti
Research Products respectively. Rabbit polyclonal and
mouse monoclonal anti-GFP antibodies were obtained
from Clontech. A rabbit polyclonal antibody specific for
APC (M-APC; ref [16]) was a kind gift from Dr Inke
Nathke, University of Dundee, UK. All secondary antibod-
ies were highly cross-adsorbed Alexa 488 and 594 conju-
gates obtained from Molecular Probes. Nocodazole was
obtained from Sigma.
Plasmids
The GFP, EB1-GFP and EB1-∆N2-GFP expression plas-
mids used in this work have been described previously
[3,7,17].
Immunofluorescence
COS-7 cells were cultured and transfected on glass cover-
slips. Cultures were processed for immunocytochemistry
using methanol fixation 18 h after transfection and
imaged using a Leica TCS-SP confocal microscope as
described previously [7]. Alternatively, cells were imaged
by fluorescence microscopy using a Zeiss Axiovert 200
inverted microscope coupled to an Orca II ER CCD cam-
era controlled by AQM6 software (Kinetic Imaging, Not-
tingham, UK). Figures were assembled using Adobe
Photoshop 7.
Time-lapse fluorescence imaging
Cells were grown and transfected in 35 mm glass-bot-
tomed culture dishes (Iwaki brand; Asahi Techno Glass
Corporation, Japan) obtained from Bibby Sterilin. 14–18
h after transfection the cell culture medium was replaced
by 1.5 ml of pre-warmed medium containing 20 mM
HEPES. The cells were then transferred to a Zeiss Axiovert
200 inverted microscope with the stage enclosed in a
heated chamber (Solent Scientific, UK) maintained at
37°C. After 15 min equilibration cells were examined by
fluorescence microscopy using a Zeiss Plan Apochromat
63X/1.4NA oil immersion lens or by fluorescence and
phase contrast microscopy using a Zeiss A-Plan 40X/
0.65NA dry lens. An excitation/emission filterset opti-
mised for eGFP imaging was used for fluorescence
microscopy (Chroma Technology Corp., Brattleboro,
USA; filterset ID 86007). Time-lapse images were
obtained using Ludl shutters and a Hamamatsu Orca II ER
camera. Microscope, camera, filterwheels and shutters
were controlled by AQM 6 software (Kinetic Imaging,
Nottingham, UK). Typically, images were obtained using
1 × 1 binning and exposure times of less than 250 ms/
frame with time-lapse intervals ranging between 5s and
30s. Time-lapse image series were saved as uncompressed
AVI files then cropped, compressed and converted into
Quicktime movies using Adobe ImageReady 7. Some
movies are presented using an inverted greyscale colour
look-up table to enhance the visibility of small structures.
Particle tracking analyses were performed using Motion
Analysis software from Kinetic Imaging.
Cell extractions, SDS-PAGE and Western blotting
Cells were harvested by scraping and collected by centrif-
ugation 18 h after transfection. Cell pellets were resus-
pended in ice-cold PBS containing 0.1% Triton X-100, a
mixture of protease inhibitors (Complete EDTA-free tab-
lets, Roche Diagnostics, Germany), 2 mM EDTA, 50 mM
sodium fluoride and 100 µM sodium orthovanadate
(PBS/TX100) then incubated on ice for 5 min with occa-
sional mixing. Insoluble and soluble fractions were sepa-
rated by centrifugation at 12000 g for 5 min in a benchtop
microcentrifuge. Once the supernatant was removed to a
fresh tube the pellet was resuspended in a volume of PBS/
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TX100 equivalent to that of the removed supernatant. An
equal volume of 2x concentrated SDS-PAGE sample load-
ing buffer containing 5 mM DTT was added to both the
soluble and insoluble fractions, followed by boiling for 5
min. To reduce viscosity pellet samples were passed
repeatedly through a narrow gauge needle attached to a
syringe before gel loading. Unused sample was snap fro-
zen in liquid nitrogen and stored at -80°C until needed.
SDS-PAGE and Western blotting were performed essen-
tially as described previously [1]. Blots were probed using
fluorescently conjugated secondary antibodies and visual-
ised using a Li-Cor Odyssey quantitative Western Blotting
system. Equal loading of different cell extracts onto SDS-
PAGE gels and subsequent transfer on to Western blotting
membranes was confirmed by quantitative immunoblot-
ting with a monoclonal β-actin antibody. Gel images were
processed and converted into greyscale images using
Adobe Photoshop 7. The images of some blots shown in
this study have been cropped due to size considerations;
only regions where no specific immunoreactivity was
observed after overexposure have been removed.
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